AstraZeneca’s black week in Europe continues. After the suspension of vaccination against Covid-19 with its dose in several European countries last week, this Monday they have joined Italy, Germany and France.
The European Medicines Agency (EMA) has returned to pronounce this afternoon recalling that, for the moment, the benefits associated with administering the AstraZeneca vaccine far outweigh the potential risks.
The European body has said that its Pharmacovigilance committee will continue to review the data tomorrow and that it has convened next Thursday an extraordinary meeting in which the conclusions of its experts will be made public.
Italy has suspended this Monday as a precaution the massive vaccination with AstraZeneca in the country after the recent cases of thrombosis in Europe, sources from the Italian Medicines Agency (AIFA) have confirmed to EFE. The measure adds to the suspension last week only with a specific batch of vaccine.
Germany has also preventedly suspended vaccination with the AstraZeneca formula against the coronavirus after detection of several cases of thrombosis, the Ministry of Health reported this Monday.The German Government thus follows the recommendation of the Paul Ehrlich Institute (PEI), competent in the matter, which it considers to be It is necessary to verify the potential relationship between this vaccine and new cases of thrombosis registered in Europe after inoculation.The Ministry of Health pointed out that it will be in any case the European Medicines Agency (EMA) who ultimately decides “if this new information affects the authorization of the vaccine and in what form ”.
Lastly, andFrench President Emmanuel Macron announced this Monday that France is temporarily suspending the use of the AstraZeneca vaccine, pending receipt of the opinion this Tuesday of the European Medicines Agency (EMA).
“There we suspend see you tomorrow afternoon“, Said in a joint conference with the President of the Spanish Government, Pedro Sánchez, with whom he holds the XXVI bilateral summit between the two countries in the French city of Montauban.Macron clarified that the decision has been made on recommendation and in connection with the French health authorities.
In Spain, according to the chain To be, the Minister of Health, Carolina Darias, has convened the Interterritorial Health Council for this Monday afternoon to see if added to the temporary suspension of vaccination with this drug. The EMA has so far identified about thirty cases of thrombosis after a dose of the AstraZeneca vaccine. In total, some five million doses have been administered in the European Union (EU).The EMA has pointed out that the rate of thrombosis cases among those vaccinated “It is not greater than that of the population as a whole”, but he added that it is necessary to analyze in detail what happened.The AstraZeneca formula, weighed down from the start Due to doubts about its effectiveness and possible side effects, it is the third authorized in the EU, behind those of BioNTech / Pfizer and Moderna.Following its authorization in the EU, the German Government – following the indications of the PEI – recommended using the AstraZeneca only for people between 18 and 64 years, considering that insufficient tests had been carried out with older people.Recently, and with the aim of accelerating the vaccination campaign, the federal government and the federated states advocated for remove this restriction and use AstraZeneca’s across the entire population, like the other two vaccines against coronavirus